A star fund manager is betting against the boom in Guinness amid fears that the rise of weight loss drugs could curtail ...

In a letter to investors, Smith (pictured) said he had sold his Fundsmith Equity fund's shares in Diageo after holding the ...

Eli Lilly and Novo Nordisk continue to ramp production facilities and capacity for booming weight-loss drugs like Wegovy ... and demand issues have led to a boom in pharmaceutical cybercrime ...